Affinity DataKi: 0.0110nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0120nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0160nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0160nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0210nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0260nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0270nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0300nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0360nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0410nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0570nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.0670nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.130nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.310nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.420nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.430nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 0.450nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 3.20nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 3.20nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 16nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 28nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 44nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 480nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
Affinity DataKi: 520nMAssay Description:Inhibition of Magnaporthe grisea scytalone dehydrataseMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.25nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.25nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.260nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.380nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.380nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.460nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair